Skip to main content

SoG responds to latest MHRA guidance on the AstraZeneca vaccine

Following today’s update from the MHRA and the new JCVI guidance, as an extra cautionary measure, the Bailiwick Vaccination Programme will ensure that anyone under 30, with no underlying health risk, will receive the Pfizer-BioNTech vaccine (or the Moderna Vaccine when available) when they are invited to make their vaccine appointments.

Those under 30 who are due to receive a second dose of the Astra Zeneca vaccine and who didn’t suffer from the side effects reported by the MHRA should have the second dose as the data from the MHRA suggests that all reported adverse incidents of this type have been associated with the first dose of vaccine to date.

Read the media release.